Loading...
Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency
Clinical trials of bone marrow mesenchymal stem cell (MSC) therapy have thus far demonstrated moderate and inconsistent benefits, indicating an urgent need to improve therapeutic efficacy. Although administration of sufficient cells is necessary to achieve maximal therapeutic benefits, documented MS...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Physiological Society
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3492833/ https://ncbi.nlm.nih.gov/pubmed/22843797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpcell.00191.2012 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|